Mirum Pharmaceuticals Inc (MIRM)
25.30
+0.23
(+0.92%)
USD |
NASDAQ |
Apr 30, 14:07
Mirum Pharmaceuticals Shareholders Equity (Quarterly): 248.67M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 248.67M |
| September 30, 2023 | 269.08M |
| June 30, 2023 | 78.61M |
| March 31, 2023 | 141.15M |
| December 31, 2022 | 142.04M |
| September 30, 2022 | 169.30M |
| June 30, 2022 | 110.69M |
| March 31, 2022 | 108.93M |
| December 31, 2021 | 120.21M |
| September 30, 2021 | 56.40M |
| Date | Value |
|---|---|
| June 30, 2021 | 95.74M |
| March 31, 2021 | 133.88M |
| December 31, 2020 | 172.10M |
| September 30, 2020 | 120.26M |
| June 30, 2020 | 136.21M |
| March 31, 2020 | 156.12M |
| December 31, 2019 | 130.35M |
| September 30, 2019 | 146.20M |
| June 30, 2019 | -27.95M |
| March 31, 2019 | -16.06M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-27.95M
Minimum
Jun 2019
269.08M
Maximum
Sep 2023
132.00M
Average
133.88M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences Inc | 17.46B |
| Vanda Pharmaceuticals Inc | 544.91M |
| Sarepta Therapeutics Inc | 859.34M |
| Puma Biotechnology Inc | 53.44M |
| Reneo Pharmaceuticals Inc | 88.61M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 646.62M |
| Total Liabilities (Quarterly) | 397.95M |
| Debt to Equity Ratio | 1.232 |
| Current Ratio | 4.451 |
| Net Debt Paydown Yield | -4.44% |